Decentralized Manufacturing: Reshaping the Future of Production
Decentralized manufacturing is reshaping production through distributed facilities that improve agility, resilience, customization, and sustainability
In time of dynamic market demands, disruptive technologies, and global uncertainties, the model of manufacturing is undergoing a transformative shift towards decentralization. This discussion explores the concept of Decentralized Manufacturing, a strategic model where production facilities are distributed across regions, fostering regional responsiveness, reducing transportation costs, and enhancing supply chain resilience. The session delves into the numerous benefits of this approach, including increased customization, reduced lead times, and improved flexibility to adapt to dynamic markets.
Highlighting the significance of decentralization in mitigating operational risks, the presentation discusses how this model accommodates regulatory compliance variations while contributing to sustainability goals. The audience will gain insights into the critical factors influencing the success of decentralized manufacturing, such as effective coordination, standardized quality control, and robust communication systems.
Examples will illustrate successful implementations in pharmaceutical manufacturing. As industries embrace decentralization, attendees will leave with a comprehensive understanding of its transformative potential, the challenges to be addressed, and actionable insights for incorporating decentralized manufacturing strategies into their organizational frameworks.
Key Learning Objectives:
- Understand how decentralized manufacturing is reshaping production
- Learn how to leverage decentralization for your production
- Identify the critical enablers to deploy decentralized manufacturing models
Who should attend:
- Production manager
- Manufacturing Team
- QA/QC Specialist
- Regulatory Officer
- Environmental Monitoring Specialist
- Process Engineer
Speakers
Mark Hallworth
Global Pharma and Sr. GMP Advisor, Life Sciences Division
Mark Hallworth is a globally recognized authority in pharmaceutical contamination control, specializing in the design, validation, and implementation of GMP-compliant environmental monitoring systems. With decades of experience, he has led more than 200 projects across cleanroom facilities, focusing on regulatory compliance, data integrity, and system performance. Mark has contributed to the development of particle counters for hazardous environments and 21 CFR Part 11ācompliant software for batch release and test management. He has authored over 100 technical papers and contributed to leading industry publications and reference books. Mark frequently presents at international forums, including the Parenteral Drug Association (PDA) and ISPE, where he teaches best practices in cleanroom monitoring and GMP compliance. Additionally, Mark served on the ISO 14644-21 technical committee and received the IEST James Mildon Award for advancing knowledge in contamination control. His work continues to shape standards and practices across the global pharmaceutical and biotechnology industries.
